☆ 4.7 Letter

ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells

LEUKEMIA (2010)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 24, Issue 4, Pages 869-872

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2009.300

Keywords

-

Categories

Oncology Hematology

Funding

  1. NCI NIH HHS [P30 CA016672, P30 CA046592] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [P30CA016672, P30CA046592] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.